Uli Hacksell - Net Worth and Insider Trading
Uli Hacksell Net Worth
The estimated net worth of Uli Hacksell is at least $2 Million dollars as of 2024-09-20. Uli Hacksell is the CEO of ACADIA Pharmaceuticals Inc and owns about 115,549 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $2 Million. Uli Hacksell is also the Director of Avalo Therapeutics Inc and owns about 7 shares of Avalo Therapeutics Inc (AVTX) stock worth over $64. Details can be seen in Uli Hacksell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Uli Hacksell has not made any transactions after 2017-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Uli Hacksell
Uli Hacksell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Uli Hacksell owns 3 companies in total, including Avalo Therapeutics Inc (AVTX) , Adhera Therapeutics Inc (ATRX) , and ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Uli Hacksell’s form 4 insider trades.
Insider Ownership Summary of Uli Hacksell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2017-06-09 | director |
| ATRX | Adhera Therapeutics Inc | 2018-07-01 | director |
| ACAD | ACADIA Pharmaceuticals Inc | 2014-12-15 | director & Chief Executive Officer |
Uli Hacksell Latest Holdings Summary
Uli Hacksell currently owns a total of 2 stocks. Among these stocks, Uli Hacksell owns 115,549 shares of ACADIA Pharmaceuticals Inc (ACAD) as of December 15, 2014, with a value of $2 Million and a weighting of 100%. Uli Hacksell also owns 7 shares of Avalo Therapeutics Inc (AVTX) as of June 9, 2017, with a value of $64 and a weighting of 0%.
Latest Holdings of Uli Hacksell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2014-12-15 | 115,549 | 16.54 | 1,911,180 |
| AVTX | Avalo Therapeutics Inc | 2017-06-09 | 7 | 9.11 | 64 |
Holding Weightings of Uli Hacksell
Uli Hacksell Form 4 Trading Tracker
According to the SEC Form 4 filings, Uli Hacksell has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 30,000 shares on December 15, 2014, which brought Uli Hacksell around $930,000.
According to the SEC Form 4 filings, Uli Hacksell has made a total of 0 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 7 shares on June 9, 2017, which cost Uli Hacksell around $15,000.
Insider Trading History of Uli Hacksell
- 1
Uli Hacksell Trading Performance
GuruFocus tracks the stock performance after each of Uli Hacksell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Uli Hacksell is 32.23%. GuruFocus also compares Uli Hacksell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Uli Hacksell within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Uli Hacksell's insider trading performs compared to the benchmark.
Performance of Uli Hacksell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 70.5 | | | | | |
| Relative Return to S&P 500(%) | 70.77 | | | | | |
Uli Hacksell Ownership Network
Uli Hacksell Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Uli Hacksell is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Uli Hacksell made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 878 shares were bought by its insiders, resulting in a net sale of 14,470 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Uli Hacksell Mailing Address
Above is the net worth, insider trading, and ownership report for Uli Hacksell. You might contact Uli Hacksell via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
